This website is fully funded and supported by Gilead Sciences Europe Ltd

Gilead is dedicated to supporting communities with life‑threatening diseases

In December 2019, a novel virus causing flu-like symptoms emerged in Wuhan, Hubei Province, China. Within three months, the World Health Organization declared the spread of the coronavirus-19 (COVID-19) to be a global pandemic.1 Since then, COVID-19 has drastically changed the world in which we live.

For more information on symptoms, testing, vaccination and self-isolation, please click here.

At Gilead we remain committed to pursuing the impossible, working tirelessly to bring forward medicines for life-threatening diseases. If you are a member of the public and would like to access the patient information on Gilead COVID-19 medicines, click here.

REFERENCES AND FOOTNOTES

COVID-19, coronavirus disease 2019.

  1. World Health Organisation. WHO Director-General opening remark at the media briefing on COVID-19 – 11 March 2020.
    Available at: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020. Accessed September 2021.